AstraZeneca: Patient Compliance trials

The registry lists 20 Patient Compliance studies with AstraZeneca as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 3 1Phase 4 1No phase 18(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Patients' Compliance to Home Nebulizer Therapy for Children's Asthma in ChinaCompletedNCT03156998
• Better Diabetes Control, Quality - Educate to Achieve Compliance.CompletedNCT01728714
• Hypoglycemia- and Weight-related Quality of Life in Patients With Diabetes Mellitus Type 2 on Sulfonylurea Derivatives.TerminatedNCT01244646
• Gastroprotective Agent Utilization and Compliance in Patients > 60 Years Taking Low-dose Aspirin in FranceWithdrawnNCT01238809
• Gastroprotective Agent Compliance in Patients at Risk Suffering From a Gastrointestinal(GI) UlcerWithdrawnNCT01215058
• Gastroprotective Agent Utilization and Compliance in Elderly Patients Taking Non-steroidal Anti-inflammatory Drug (NSAID) in FranceCompletedNCT01211652
• Epidemiology Study in Postmenopausal Women With Estrogen Receptor Positive Breast CancerCompletedNCT01208779
• Evaluation of Compliance With Management of Acute Coronary Syndrome on Discharge From Cardiac Intensive CareTerminatedNCT01105325
• Arimidex Therapy Compliance Electronic Monitoring SystemCompletedNCT00936442
• Parameters of Acceptability, Compliance and Efficacy of Fulvestrant in Post-menopausal Patients With Advance Breast CancerCompletedNCT00878930
• CARE - Quality Improvement in Asthma Secondary Prevention in Primary Care, Through Delegation of Consultations to the Nurse.CompletedNCT00714038
• Adherence to Gastro-protection in Non-steroidal Anti-inflammatory Drug (NSAID) Using PatientsCompletedNCT00699725
• Compliance of Patients With Essential Hypertension Treated With Candesartan or Candesartan/HydrochlorothiazideCompletedNCT00608153
• Patient's Anastrozole Compliance to Therapy ProgrammeTerminatedNCT00555867
• COmpliance and Efficacy in Mono and Combination Tablet Study ATacand/Atacand PlusCompletedNCT00526279
• Symbicort SMART (Symbicort Maintenance And Reliever Therapy)CompletedNCT00523679
• APOLLO(Aromatase Inhibitor Patient cOmpLiance Program With qoL Questionaire)CompletedNCT00523315
• ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL GoalsWithdrawnNCT00396240Phase 4
• Rosuvastatin ORBITAL GermanyCompletedNCT00379249Phase 3
• Improved Quality of the Treatment and Increased Compliance in Asthmatics Through the Dialog Tool Soren - Between Patient and CaregiverCompletedNCT00272727Not applicable